In three different laboratory studies an attempt was made to elucidate the mechanism of action of the immunotherapeutic Gynatren/SolcoTrichovac. The results show that the protective effect of immunization with this vaccine is based on an immunologic cross-reaction between the antigens contained in the vaccine and those of Trichomonas vaginalis. These immune phenomena are more cellular than humoral.